Our Collab Network members are not only experts within their own domain but educators with the research community. Learn more about the discoveries and findings our collaborators are achieving with IDT.
The future of personalized genomics
Manja Meggendorfer is the Head of Molecular Genetics at Munich Leukemia Laboratory (MLL), where she oversees various R&D activities such as the 5,000 genome project, which is aimed at better understanding the genetic factors behind leukemia. She received her Master of Science in Biology from the Ludwig-Maximilians-University in Munich and her PhD. in collaboration with the Helmholtz Center Munich working on gene regulation within the architecture of the cell nucleus. After her post-doctorate, she moved to the field of hematology as a scientist in the department of molecular genetics at MLL. In combination with her MBA in Health Care Management, Manja hopes to improve the diagnostic and prognostic work associated with routine diagnostic approaches for leukemia or lymphoma patients.
Leveraging automation to minimize errors, reduce hands-on time, and increase throughput
PerkinElmer delivers optimized, automated solutions designed to improve the efficiency of genomic workflows. These solutions eliminate the challenges associated with genomic analysis by providing labs with complete, single-source solutions encompassing everything from sample to solution.
Automated workflow solutions have been developed for a range of applications including single- cell RNA-seq, SARS-CoV-2 testing, nucleic acid isolation and PCR setup, NGS sample prep, AAV characterization, CRISPR fragment analysis, molecular cytogenetics, and protein characterization. By enabling complete application-based solutions, PerkinElmer increases your throughput while simplifying the generation of accurate, reproducible analysis.
We have partnered with PerkinElmer to provide IDT customers access to automation protocols and scripts for use on their PerkinElmer liquid handling instruments. Featured below are some of the existing protocols that have already been developed. Request access today!